The authors continue their discussion of pharmacological and nonpharmacological therapies with a focus on criteria for the best agent, the subtypes of breakthrough pain, and the economic and quality-of life considerations.
|Original language||English (US)|
|Number of pages||8|
|Journal||P and T|
|State||Published - Jun 2005|
ASJC Scopus subject areas